Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0431A vs Pioglitazone in Type 2 Diabetes
NCT00532935Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Jan 2008; status: completed.
02
Drugs
sitagliptinliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00532935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532935.